Basilea Pharmaceutica AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	159.8	120.71	59.93	84.66	53.7
Short-Term Investments	-	-	-	-	95
Cash & Short-Term Investments	159.8	120.71	59.93	84.66	148.7
Cash Growth	32.38%	101.41%	-29.21%	-43.07%	-8.08%
Accounts Receivable	13.49	8.88	27.89	33.15	24.95
Other Receivables	49.79	49.31	30.26	28.55	39.5
Receivables	63.28	58.18	58.15	61.7	64.45
Inventory	21.56	31.61	26.41	24.24	22.78
Restricted Cash	2.54	3.85	4.39	1.91	1.25
Other Current Assets	4.56	6.56	3.27	2.85	3.88
Total Current Assets	251.73	220.91	152.15	175.36	241.07
Property, Plant & Equipment	18.15	18.98	20.55	21.57	2.92
Other Intangible Assets	0.37	0.37	0.55	0.58	0.63
Long-Term Deferred Tax Assets	11.7	17.33	-	-	-
Other Long-Term Assets	0.05	0.17	0.04	22.07	0.26
Total Assets	282	257.76	173.29	220.85	247.27
Accounts Payable	15.06	11.49	5.85	0.19	10.62
Accrued Expenses	23.9	21.5	13.1	18.9	27.9
Current Portion of Long-Term Debt	-	-	15.45	37.47	123.51
Current Portion of Leases	2.06	2.06	2.06	1.99	0.9
Current Income Taxes Payable	-	-	-	-	0.5
Current Unearned Revenue	1.57	1.62	1.23	1.23	1.23
Other Current Liabilities	6.62	8.89	9.9	15.07	9.76
Total Current Liabilities	49.22	45.56	47.59	74.85	174.41
Long-Term Debt	75.44	95.91	95.46	131.36	94.54
Long-Term Leases	11.72	13.7	15.64	16.32	0.01
Long-Term Unearned Revenue	9.46	11.39	9.46	10.69	11.93
Pension & Post-Retirement Benefits	8.23	10.21	15.15	8.34	24.99
Other Long-Term Liabilities	-	-	0	-0	-
Total Liabilities	154.06	176.77	183.29	241.56	305.87
Common Stock	13.32	13.17	13.1	13.09	12.99
Additional Paid-In Capital	1,052	1,048	1,042	1,037	1,030
Retained Earnings	-882.57	-923.29	-1,001	-1,011	-1,023
Treasury Stock	-51.28	-51.7	-54.01	-56.07	-56.56
Comprehensive Income & Other	-3.9	-4.74	-10.21	-3.79	-21.62
Shareholders' Equity	127.94	81	-10	-20.72	-58.61
Total Liabilities & Equity	282	257.76	173.29	220.85	247.27
Total Debt	89.22	111.67	128.61	187.14	218.96
Net Cash (Debt)	70.58	9.04	-68.67	-102.48	-70.26
Net Cash Growth	680.74%	-	-	-	-
Net Cash Per Share	5.16	0.65	-5.66	-8.58	-6.01
Filing Date Shares Outstanding	12.29	12.13	12	11.95	11.84
Total Common Shares Outstanding	12.29	12.13	12	11.95	11.84
Working Capital	202.52	175.35	104.55	100.51	66.66
Book Value Per Share	10.41	6.68	-0.83	-1.73	-4.95
Tangible Book Value	127.57	80.63	-10.55	-21.29	-59.24
Tangible Book Value Per Share	10.38	6.65	-0.88	-1.78	-5.00
Machinery	14.85	13.61	12.86	12.98	16.62
Leasehold Improvements	2	1.8	1.8	1.8	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.